Pluri Inc.

Regulatory Filings • Feb 18, 2015

_________ false

C003�������� ��������� ����2PublicPLURISTEM THERAPEUTICS INC8543Corporation no: C12337-2001Stock Exchange/Market: NASDAQ2753381Matam Park 20 , Haifa 31905 , ISRAEL ,Tel: 074-7107171 , Fax: 074-7107172E.mail address: Info@Pluristem.ComReported via MAGNA: 18/02/2015              Time of broadcast: 09:46 09:45:30

Company site:		www.pluristem.com

Reference: 2015-02-033811

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Significant Findings in U.S. National Institutes of Health�s Trial of Pluristem�s PLX-R18 Cells for Treatment of Acute Radiation Syndrome

PluristemNIAID_Final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 12/01/2015
- - -
Name of the Signatory: : Yanay Yaacov , Position of Signatory in the reporting corporation: President & Chief Operating Officer , Name of Employer Company: .
Matam Park Telephone: 074-7107171 , Facsimile: 074-7108673 , E-mail: yaky@pluristem.com 1